Semaglutide Weight Loss Program
When Semaglutide first hit the market, we were slightly skeptical about its effectiveness. However, we have been pleasantly surprised with this medication and have high hopes that it could be very useful to help treat obesity in the modern day. Treating weight issues and making positive changes to your diet and lifestyle can dramatically decrease your risk of having serious diseases as you age. We are very excited to be offering Semaglutide at The Natural Path and the results we have seen in MOST of our patients have been nothing short of exciting. The ideal candidate has at least 10-100+ lbs. of fat to lose and has not been able to do so with diet and exercise. This is also a great program for those with insulin resistance and strong food cravings.
FDA Approved Treatment
Semaglutide is a glucagon-like peptide-1 FDA approved for the treatment of overweight and obesity. Weekly self-administered injections work by suppressing appetite and improving blood sugar metabolism. In June 2021, the U.S. Food and Drug Administration approved this novel weight loss drug for Americans with a BMI of 27 with a co-morbid condition or a BMI over 30. This weekly injection is the first approved drug for weight management in over 7 years and offers a safe and effective way to suppress appetite and lose weight, while learning how to create and follow a lifestyle diet. At this time, the medication can also be used “off label” for those with a BMI below 27 who have weight to lose. Semaglutide is being reviewed at this time to be FDA approved for general weight loss in the future.
How does Semaglutide work?
Semaglutide works by mimicking a hormone your body naturally makes called glucagon-like peptide-1 (GLP-1) which acts on areas of the brain that regulate appetite and food intake, leading to reduced caloric intake.
While this peptide-mimicking drug is very effective for weight loss, research support additional benefits as well, including:
- Reduced blood pressure
- Helping to stop the progression of plaque in blood vessels
- Reduced average blood glucose
- Reduced triglycerides
"I'm just ecstatic with the results. I've lost 22 pounds in the past 3 months, which might not sound like much to some, but for me, that's nothing short of a miracle...
The weight loss has been consistent, and it has happened with ease. Dr. Cara has been amazing at guiding me through the process and helping me create a lifestyle diet so that this can be the gift that keeps on giving. I feel better than ever.”
Semaglutide Weight Loss Program: Frequently Asked Questions
Semaglutide is a once a week, subcutaneous injectable medication that has been shown to reduce appetite and suppress cravings. When used in combination with diet and exercise, Semaglutide can help with blood sugar control in type 2 diabetics. It has also been shown to help with weight loss. Semaglutide belongs to a class of medications – glucagon-like peptide-1 (GLP-1) agonists, which mimic the hormone GLP-1 to lower blood sugar levels after eating. Semaglutide is a generic form of the medication Wegovy that has been used to help diabetics lose weight and control blood sugar for 10 years. There is a significant amount of data showing the safety and effectiveness of Semaglutide as a medication for weight loss.
No, Semaglutide is not a type of insulin or a substitute for insulin. Semaglutide does stimulate your pancreas to release insulin when glucose (sugar) is present. Because Semaglutide relies upon your body’s own insulin to have this effect, Semaglutide isn’t used when your pancreas can’t make insulin, such as in patients in type 1 diabetes.
Glucagon-like peptide 1 (GLP-1) is a hormone that causes huge effects on the regulation of blood sugar by stimulating glucose-dependent insulin secretion. Insulin is a hormone that promotes sugar uptake by the cells, stores sugar as glycogen, promotes the building of fat, and signals the body to build skeletal muscle. In addition, GLP-1 inhibits glucagon release (which slows down the release of sugar into the blood so that you burn more fat), slows down gastric emptying (makes you feel full), and lowers the desire for food intake (because you feel full).
No, Semaglutide is not a stimulant.
GLP-1 agonists like Semaglutide help to control your blood sugar. Those taking it also tend to lose weight. GLP-1, the key hormone involved, slows down stomach emptying and in addition, can stimulate your pancreas to release insulin. Semaglutide also blocks a hormone that causes your liver to release sugar (glucagon). Together, these functions can help you feel less hungry, causing you to eat less food and lose more weight.
Yes, it is believed that Semaglutide can help curb your appetite. In addition to slowing gastric emptying to make you feel full for longer, GLP-1 also plays a direct role with appetite.
With Semaglutide, you will slowly work your way up to the target dose at which time you will see the most amount of weight loss. We prefer to keep the max dose at 1 mg to avoid potential side effects. Clinically, we have found the max dose of 1 mg to be highly effective in our patient population. It is important to keep in mind that weight loss can take time. You will see the best results when you are using it in combination with a healthy diet and exercise. Sometimes the medication may not work for you, or you may not be able to tolerate it. Most do well.
Currently, Semaglutide is only FDA-approved to help with blood sugar control in type 2 diabetes and to lower the risk of major cardiovascular events (like heart attack and stroke) in people with both type 2 diabetes and heart disease. If you are taking Semaglutide for either of these reasons, you’ll take it as directed by your healthcare provider since you are using it to manage a chronic condition. But if you do not have type 2 diabetes and are looking to try Semaglutide to help with weight loss, we’ll have a better idea of long-term safety once the FDA reviews data for this new indication. What we do know is that study participants received treatment for a period of 68 weeks (about 1.5 years) during each of the four trials conducted.
Yes. Semaglutide is safe and effective when used as indicated. Yet, safe doesn’t mean that there aren’t risks. Semaglutide also carries a boxed warning about thyroid C-cell tumors occurring in rodents (with unknown risk in humans), and Semaglutide shouldn’t be used if you or your family have a history of certain thyroid cancers. Semaglutide should not be used in people with type-1 diabetes or a history of pancreatitis. Semaglutide should be used cautiously for people on other blood sugar lowering medications. It should also not be used if you are under 18, pregnant, trying to get pregnant or breastfeeding.
At The Natural Path, we do not bill any insurance companies – fee for service only.
In early December, Novo Nordisk submitted a new drug application (NDA) with priority review to the FDA. Generally, it takes the FDA about 10 months to review an application. For now, general weight loss is considered an “off label” use of the medication.
The common side effects are nausea, vomiting, constipation, diarrhea, and stomach pain. It is also advised to avoid or reduce alcohol consumption on the program.